Ruzanna Papyan, Chief of Pediatric Oncology Department at PCBDC of Armenia, Clinical Research Physician at Immune Oncology Research Institute, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Check out our new article, ‘Adaptive Clinical Neuroblastoma Risk Groups—Tailoring Treatment in Low- and Middle-Income Countries,’ that has just been just published!
This work reflects a truly international collaboration and a shared commitment to adapting neuroblastoma risk stratification to real-world settings.
Grateful for the collaboration, the shared vision, and the ongoing efforts to improve outcomes for children with neuroblastoma globally.”
Title: Adaptive Clinical Neuroblastoma Risk Groups—Tailoring Treatment in Low- and Middle-Income Countries: An International Neuroblastoma Risk Group Project
Authors: Wendy B. London, Gabriela Villanueva, Derek Shyr, Jaques van Heerden, Soad Fuentes-Alabi, Raya Saab, Derek Harrison, Ruzanna Papyan, Hoa Thi Kim Nguyen, Dolly Noun, Joyce Kambugu, Jelena Rascon, Miklos Garami, Dongjing Guo, Paige Kao, Arlene Naranjo, Julie R. Park, Susan L. Cohn, Carlos Rodriguez-Galindo, Katherine K. Matthay
Read the Full Article on JCO Global Oncology
More posts featuring Ruzanna Papyan.